Fountain Life Review

Fountain Life — Provider Profile

Overview

Fountain Life is an ultra-premium longevity diagnostics and treatment company founded in 2019 by Peter Diamandis (founder of XPRIZE and Singularity University) and physician-scientist Dr. William Kapp. It operates physical diagnostic centers — currently in Orlando, Dallas, New York, and a small number of additional cities — that offer the most comprehensive medical diagnostics available outside of a hospital setting: full-body MRI, brain MRI, coronary CT angiography, liquid biopsy for early cancer detection, and a biomarker panel running well over 100 data points. Treatment protocols, including GLP-1 prescriptions, are managed through follow-up telehealth visits after the in-person diagnostic phase.

The clinical case for Fountain Life's model is straightforward: many serious conditions — early-stage cancers, cardiovascular disease, metabolic dysfunction — are significantly more treatable when caught early, and standard annual physicals do not catch them early. A full-body MRI plus comprehensive biomarker panel surfaces findings that would otherwise go undetected for years. For high-net-worth patients who can absorb the cost, Fountain Life offers genuine diagnostic depth that no standard telehealth platform — including the other premium providers reviewed on this site — can approach.

GLP-1 prescriptions at Fountain Life are a component of that broader metabolic optimization program. Physicians review a patient's full biomarker picture — cardiovascular risk, insulin sensitivity, inflammatory markers, hormones, body composition via DEXA — and make GLP-1 recommendations in that context. This is thorough clinical practice. It is also important to state plainly: most patients seeking GLP-1 access do not need a $10,000 diagnostic workup to receive an appropriate prescription. The diagnostics are impressive; the GLP-1 prescribing is good clinical care; the price is a structural barrier for 99% of patients who could clinically benefit from these medications.

Medications Offered

• GLP-1 receptor agonists (semaglutide, tirzepatide) within a metabolic optimization protocol — verify current formulary at fountainlife.com
• Hormone replacement and optimization protocols
• Full longevity treatment menu based on diagnostic findings
• Peptide protocols (subject to regulatory status; confirm current availability)

Note: As of April 2026, compounded semaglutide lost its FDA shortage exemption in February 2025. Compounded tirzepatide faces 503B compounder enforcement deadlines in April 2026. Confirm Fountain Life's current medication sourcing at fountainlife.com.

Pricing

All pricing is a April 2026 estimate. Fountain Life's programs are highly individualized and costs vary by location and services selected. Verify current pricing at fountainlife.com. Medication costs are additional. This is among the highest-cost healthcare options reviewed on this site.

States Served

Fountain Life requires an in-person visit to one of its diagnostic centers for the initial workup. Centers are currently located in a small number of U.S. cities including Orlando, Dallas, and New York. Follow-up care and treatment management are conducted via telehealth and can be delivered to patients across most states after the initial in-person visit. Patients who do not live near a center must travel for the diagnostic phase. International clients are accommodated at select locations.

Insurance

• Does not accept insurance for any programs or services
• HSA/FSA may apply to some components — confirm with Fountain Life and your plan administrator
• No Medicare or Medicaid participation
• Some patients with flexible benefit structures may receive partial reimbursement for specific tests — this is not standard and should not be anticipated

Consultation Process

Model: In-person diagnostics required; physician-led telehealth follow-up for treatment management

1. Initial consultation call to review program options and confirm enrollment
2. In-person visit to a Fountain Life center (travel required for most patients): full-body MRI, brain MRI, coronary CT angiography, DEXA, liquid biopsy, and comprehensive lab panel over one to two days
3. Diagnostic review session with physician team — findings reviewed and explained across all modalities
4. Personalized treatment protocol developed based on full diagnostic picture; may include GLP-1, hormones, lifestyle interventions
5. Ongoing telehealth follow-up visits for treatment management and protocol adjustment
6. Annual or semi-annual diagnostic refresh

Pros

• Most comprehensive diagnostics available outside a hospital: full-body MRI, coronary imaging, liquid biopsy, and 100+ biomarker panel in a single program
• GLP-1 prescribing is made in the context of a full cardiovascular and metabolic picture — genuinely thorough clinical decision-making
• Early disease detection is clinically validated: conditions caught at Fountain Life have included early-stage cancers and asymptomatic cardiovascular disease
• Physician team is well-credentialed; longevity medicine focus attracts clinicians with strong research backgrounds
• Appropriate for high-net-worth patients who want the most thorough available medical assessment alongside treatment

Cons

• Price is the defining limitation: full programs cost $3,000–15,000+ per year, placing this out of reach for the overwhelming majority of patients
• Requires in-person travel to a diagnostic center — not accessible to most U.S. patients without significant travel cost and logistics
• GLP-1 access here is bundled into a much larger, more expensive package; patients who only need GLP-1 prescribing are paying for significant services they do not need
• Small number of physical locations limits geographic accessibility
• The longevity and performance optimization framing, while substantiated by the diagnostics, exists at the highest price point in a market that already contains expensive options

Best For

Fountain Life is appropriate for a narrow, high-net-worth patient population: adults who can comfortably absorb $5,000–15,000 per year in healthcare costs, live near or can travel to a diagnostic center, and want the most comprehensive available early-detection diagnostics alongside a longevity treatment protocol. If GLP-1 therapy is your primary goal and you meet standard clinical criteria, Fountain Life is not a rational path to that medication. If you want the most thorough diagnostic workup available in the U.S. private healthcare market and GLP-1 is one component of a broader protocol, Fountain Life delivers on that promise.

Editorial Verdict

Fountain Life's diagnostics are the real thing. Full-body MRI combined with coronary CT angiography and liquid biopsy is not wellness marketing — it is a genuinely powerful early-detection toolkit that has identified actionable findings in asymptomatic patients. The clinical quality of the program is not in question.

What must be stated plainly is this: GLP-1 therapy through Fountain Life costs an order of magnitude more than obtaining the same medications through a standard telehealth provider, with no clinical difference in the GLP-1 prescribing itself. The $10,000 diagnostic workup does not change the dose of semaglutide a patient will take. The platform is serving a different purpose — comprehensive longevity diagnostics — and GLP-1 prescribing is incidental to that purpose. Patients should be clear about which they are buying.

For the small population this platform is designed for — patients with the financial means and genuine interest in early-detection diagnostics and integrated longevity care — Fountain Life is the most capable option currently available in U.S. direct-pay medicine. For the broad population of patients seeking GLP-1 access, it is the wrong tool for the job.

Related Content

• How to Get a GLP-1 Prescription Online
• Semaglutide Cost Guide
• Who Qualifies for GLP-1 Medications
• Comparing GLP-1 Telehealth Providers